Central-acting alpha-2 adrenergic agonist
This page covers all Central-acting alpha-2 adrenergic agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Alpha-2 adrenergic receptor.
Targets
Marketed (1)
- alpha methyldopa · Radboud University Medical Center · Cardiovascular
Alpha methyldopa is a prodrug that is converted to alpha-methylnorepinephrine, which acts as a central-acting alpha-2 adrenergic agonist to reduce sympathetic outflow and lower blood pressure.
Patent intelligence
- central acting alpha 2 adrenergic agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates